Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000338316

Medchemexpress LLC SR-4835 | 2387704-62-1 | 99.7% | 100 MG
SDP

Catalog No. 5000338316
Encompass_Preferred

SR-4835 is a potent, highly selective, and ATP-competitive dual inhibitor of CDK12/CDK13. It acts synergistically with DNA-damaging chemotherapy and PARP inhibitors to induce cell death in triple-negative breast cancer (TNBC) cells.

  • Potent and highly selective ATP-competitive dual inhibitor of CDK12/CDK13
  • Acts synergistically with DNA-damaging chemotherapy
  • Induces cell death in triple-negative breast cancer (TNBC) cells
  • Inhibits CDK12/CDK13, suppressing expression of core DNA damage response proteins

Catalog No. 50-003-38316 Supplier Medchemexpress LLC Supplier No. HY130250100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

SR-4835 is a potent, highly selective, and ATP-competitive dual inhibitor of CDK12/CDK13. It acts synergistically with DNA-damaging chemotherapy and PARP inhibitors to induce cell death in triple-negative breast cancer (TNBC) cells.

  • Potent and highly selective ATP-competitive dual inhibitor of CDK12/CDK13
  • Acts synergistically with DNA-damaging chemotherapy
  • Induces cell death in triple-negative breast cancer (TNBC) cells
  • Inhibits CDK12/CDK13, suppressing expression of core DNA damage response proteins

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.